Cantos Ventures was founded in 2016 by Ian Rountree and has backed 68 companies, including 3 unicorns — Astranis (satellite broadband) and Solugen (industrial synthetic biology) among them. Fund III closed at $50M in 2022, bringing total AUM to approximately $120M.
The firm invests in what it calls near-frontier technology: climate, synthetic biology, aerospace, and next-gen computing. The sweet ...
United States
Cambridge, United States
Berlin, Germany
San Francisco, United States
Bristol, United Kingdom
New York, United States